Syros Pharmaceuticals, Inc. (SYRS)
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Address
35 CAMBRIDGE PARK DRIVE
CAMBRIDGE, MA 02140
Founded
2011
Number of Employees
68
Website
http://www.syros.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at SYRS make a trade.
Creating a free account takes less than one minute